Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review.
Leukemia research, cilt.166, ss.108239, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 166
- Basım Tarihi: 2026
- Doi Numarası: 10.1016/j.leukres.2026.108239
- Dergi Adı: Leukemia research
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
- Sayfa Sayıları: ss.108239
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet